-
Aventis Pharma S.A. et al v. Strides Inc. et al DC CAFC
- 1:11-cv-01121
- D. Del.
- Judge: Gregory M. Sleet
- Filed: 11/14/2011
- Closed: 12/01/2011
- Latest Docket Entry: 09/17/2012
- PACER
- Docket updated daily
2
Plaintiffs
2
Defendants
1
Accused
Product
2
Patents-in-Suit
18
Days in
Litigation
-
Aventis Pharma S.A. et al v. Strides Inc. et al DC CAFC
- 1:11-cv-01121
- D. Del.
- Judge: Gregory M. Sleet
- Filed: 11/14/2011
- Closed: 12/01/2011
- Latest Docket Entry: 09/17/2012
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 2 |
A composition according to claim 1, wherein, in the compound of formula (I), R represents a hydrogen atom and R.sub.1 represents a tert-butoxycarbonylamino radical.
|
Invalid (103) and Unenforceable
Entry 13 |
| 5 |
A perfusion, which contains approximately 1 mg/ml or less of compound of formula as defined in claim 1, and which contains less than 35 ml/l of ethanol and less than 35 ml/l of polysorbate, wherein said perfusion is capable of being injected
view more
|
Invalid (103) and Unenforceable
Entry 13 |
| 10 |
The composition of claim 8 wherein said taxane derivative is taxotere or an analogue or derivative thereof.
|
Invalid (103) and Unenforceable
Entry 13 |
